| Product Code: ETC6740497 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China continued to see a high concentration of controlled release drug delivery imports, with top exporting countries including Puerto Rico, Metropolitan France, Germany, Spain, and Italy. Despite a negative Compound Annual Growth Rate (CAGR) of -2.06% from 2020-2024, there was a significant decline in growth rate from 2023 to 2024 at -26.63%. The market dynamics suggest a challenging environment for controlled release drug delivery imports into China, with potential implications for market players and stakeholders to navigate in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Controlled Release Drug Delivery Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Controlled Release Drug Delivery Market Revenues & Volume, 2021 & 2031F |
3.3 China Controlled Release Drug Delivery Market - Industry Life Cycle |
3.4 China Controlled Release Drug Delivery Market - Porter's Five Forces |
3.5 China Controlled Release Drug Delivery Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 China Controlled Release Drug Delivery Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Controlled Release Drug Delivery Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in China driving the demand for controlled release drug delivery systems. |
4.2.2 Growing geriatric population in China requiring long-term medication management, fueling the need for controlled release formulations. |
4.2.3 Government initiatives and support for innovative drug delivery technologies in China boosting the market growth. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of controlled release drug delivery systems in China leading to longer development timelines. |
4.3.2 High development costs associated with controlled release drug delivery technologies posing a challenge for market players. |
4.3.3 Limited awareness and adoption of controlled release drug delivery systems among healthcare professionals and patients in China hindering market growth. |
5 China Controlled Release Drug Delivery Market Trends |
6 China Controlled Release Drug Delivery Market, By Types |
6.1 China Controlled Release Drug Delivery Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 China Controlled Release Drug Delivery Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 China Controlled Release Drug Delivery Market Revenues & Volume, By Wurster Technique, 2021- 2031F |
6.1.4 China Controlled Release Drug Delivery Market Revenues & Volume, By Coacervation, 2021- 2031F |
6.1.5 China Controlled Release Drug Delivery Market Revenues & Volume, By Micro Encapsulation, 2021- 2031F |
6.1.6 China Controlled Release Drug Delivery Market Revenues & Volume, By Implants, 2021- 2031F |
6.1.7 China Controlled Release Drug Delivery Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.1.8 China Controlled Release Drug Delivery Market Revenues & Volume, By Targeted Delivery, 2021- 2031F |
6.2 China Controlled Release Drug Delivery Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Controlled Release Drug Delivery Market Revenues & Volume, By Metered Dose Inhalers, 2021- 2031F |
6.2.3 China Controlled Release Drug Delivery Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 China Controlled Release Drug Delivery Market Revenues & Volume, By Transdermal and Ocular Patches, 2021- 2031F |
6.2.5 China Controlled Release Drug Delivery Market Revenues & Volume, By Infusion Pumps, 2021- 2031F |
6.2.6 China Controlled Release Drug Delivery Market Revenues & Volume, By Oral Controlled-drug delivery Systems, 2021- 2031F |
6.2.7 China Controlled Release Drug Delivery Market Revenues & Volume, By Drug Eluting Stents, 2021- 2031F |
7 China Controlled Release Drug Delivery Market Import-Export Trade Statistics |
7.1 China Controlled Release Drug Delivery Market Export to Major Countries |
7.2 China Controlled Release Drug Delivery Market Imports from Major Countries |
8 China Controlled Release Drug Delivery Market Key Performance Indicators |
8.1 Rate of adoption of controlled release drug delivery systems in China healthcare facilities. |
8.2 Number of patents filed for new controlled release drug delivery technologies in China. |
8.3 Investment trends in research and development of controlled release drug delivery systems in China. |
9 China Controlled Release Drug Delivery Market - Opportunity Assessment |
9.1 China Controlled Release Drug Delivery Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 China Controlled Release Drug Delivery Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Controlled Release Drug Delivery Market - Competitive Landscape |
10.1 China Controlled Release Drug Delivery Market Revenue Share, By Companies, 2024 |
10.2 China Controlled Release Drug Delivery Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here